InsidersTradesSigma
Discover the detailed record of transactions filed by SALZMAN BARRY M, Director. Officer active across 1 companies, notably Checkpoint Therapeutics, Inc.. Cumulatively, 3 reports have been logged. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Barry M. Salzman is a Board Member at Checkpoint Therapeutics, Inc. He has significant experience in corporate governance and business strategy. Barry plays a key role in guiding board decisions and implementing best practices within the company.